Trial Profile
A Phase I Clinical Study on the Hepatic Uptake, Pharmacokinetics, Safety and Tolerance of a New Oral Pentamidine Formulation in Hepatocellular Carcinoma Subjects Undergoing Thermal Ablation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2017
Price :
$35
*
At a glance
- Drugs Pentamidine (Primary)
- Indications Liver cancer
- Focus Pharmacokinetics
- Sponsors Verlyx
- 11 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 15 Oct 2015 Planned End Date changed from 1 Nov 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 15 Oct 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov record.